top of page
AB6AXuDvBK7lb2uRmO-8JqvUPHNeoXXlC7OzDijoH2tUbXZh0utA8ZOBoZ2uF3iZNJLELKmiVeoL60Y8zPs7nHPOppsXBlllsD4rU24cWfVfbJYGewmY5MPVtbmlEpR4gixmncbYb0uODdR0mbGC0aYvh2rTiqsRc8a2HO0fjh2MGum-KgEQoPxeK5zgr5KlWzzhO0aexDVcZdUXp_OVq21cRRIe0KlYAuKonpmhddCMGbJnRhwoC6dSy4fa3gthkwQmiR57kKUgk-N_uSI
Voferon WI

Why Voferon

An alternative approach to postoperative pain management

Pump-dependent workflow complexity

Opioid-related side effect concerns

Catheter-related leakage and fixation issues

Infection and removal burden

Added procedural steps for clinical staff

The Limitations of
Conventional
Approaches

Traditional postoperative pain management approaches may introduce additional complexity, workflow burden, and patient management considerations.

Opioid-based systems may be associated with systemic risks, while catheter-based wound infiltration may require additional steps such as preparation, access, fixation, monitoring, and removal.

Designed to support localized postoperative pain management

Voferon WI is a hyaluronic acid-based drug delivery system with sustained release through postoperative application.
It may reduce the need for continuous infusion devices while supporting localized postoperative analgesia.

May support a more streamlined intraoperative workflow

Designed with
fewer components

No separate catheter removal
step required

May reduce the need for
catheter access procedures

Does not require an infusion pump

AB6AXuDJOA5lI2VUXck-c6c0oyQZPaTIG35OPr5Ol2f65fR8MdVMWBIZEWPK-fQ1YTtipeaKW3Ls5krhzcVZscUmAwIC3IFc11tESzSybMj1SJlNSnJ4EA9DpNFaCsVLC8iDZpe44SbyKroW9jaJ-iw4lhswZj_6J9hT6eAftOiRfXfL9scgWocD94v9Ym04B9muHGCbN8yxuZb6HXUMXpdOWa4S5Ozharp6DHpMjHmRtqdwyD37cMXWHeVEEXHj8so6RA7w2e6BxE04BRE

Value That Matters

Clinical Value

Designed to support postoperative pain management with controlled local anesthetic exposure

Practical Value

Designed to support clinical workflow efficiency through a simplified application approach

Operational Value

May help reduce procedural complexity and device management requirements

Learn More About the Voferon Application Approach

Explore the Workflow

Important Safety Information (ISI)

Adverse Events
- Adverse events associated with the use of local anesthetics may occur
- Safety outcomes should be evaluated based on clinical use and patient condition

Product Considerations
- Designed for single postoperative use.
- Must be used in accordance with the Instructions for Use (IFU)
- Ropivacaine is not included and should be prepared separately


Additional Information
- For detailed information, refer to the Instructions for Use.

Indication

Voferon WI is a hyaluronic acid-based drug delivery system intended for managing pain after surgery.

Important Safety Information

Administration
- For local application at the surgical site only
- Intended for use by trained healthcare professionals
- Not for intravenous or intravascular use


Warnings and Precautions
- Avoid intravascular injection during administration
- Clinical judgment is required in patients with conditions affecting local anesthetic metabolism or sensitivity

bottom of page